Histologic findings of bevacizumab-treated human conjunctiva in Stevens-Johnson syndrome.


PURPOSE To present the histopathologic findings of the conjunctiva of a patient with Stevens-Johnson syndrome (SJS)-associated ocular surface neovascularization (OSN) after topical bevacizumab (TB) treatment. METHODS A 40-year-old man with SJS and OSN received topical bevacizumab (25 mg/mL) for 12 months in 1 eye in addition to previously bilaterally… (More)
DOI: 10.1097/ICO.0b013e3181cb83f2


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.